Institutional

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological malignancies. The company raised €1,500,000 of seed financing from Barcelona-based Invivo Ventures, one of Spain’s leading biomedical venture capital firms.